#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Asthma Dermatitis atopic Dementia Alzheimer's type Type 2 diabetes mellitus Breast cancer metastatic Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Inflammatory myofibroblastic tumour Astrocytoma malignant Metabolic disorder Thrombocytosis Retinopathy of prematurity Hypocalcaemia Gastroenteropancreatic neuroendocrine tumour disease Spinal muscular atrophy Ventricular tachycardia Hepatitis D Hereditary optic atrophy Mantle cell lymphoma stage III Scleroderma associated digital ulcer Rhabdoid tumour Round cell liposarcoma More trials…

    Learn about Rare Diseases

    Erdheim-Chester disease – Trials in Disease Hypereosinophilic syndrome – Diagnostics Adrenocortical carcinoma – Diagnostics Nephroblastoma – Basic Information Chronic granulomatous disease – Diagnostics Propionic acidaemia – Basic Information Nodal marginal zone B-cell lymphoma – Diagnostics Andersen-Tawil syndrome – Basic Information Focal segmental glomerulosclerosis – Treatment VEXAS syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cdr132L Mercaptopurine Monohydrate Tamuzimod Acetate Entrectinib Anb032 Vidofludimus Calcium Kan-101 Sufentanil Citrate RO7795081 Hdp-101 Follitropin Beta Levamisole Hydrochloride Ht-29-A GRNA-001 Doxorubicin Hydrochloride Calcium Chloride Hexahydrate Efruxifermin Ripasudil Clavulanic Acid Methohexital Sodium More therapies…

    Learn about Your Condition

    Osteopenia Pulmonary congestion Huntington's disease Pancreatitis chronic Systemic infection Lymphoma Bronchopulmonary aspergillosis Peritoneal abscess Diffuse large B-cell lymphoma Factor VIII deficiency Splenic marginal zone lymphoma Nasopharyngeal cancer Muscle spasticity Radiation skin injury Testicular germ cell cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier De Roubaix

Centre Hospitalier De Roubaix

11 Boulevard Lacordaire, Hopital Victor Provo, Roubaix, 59100, France

Want to learn more about this study or check if you can participate? Contact us.

  • One-Year Effectiveness Study of Guselkumab in Adults with Crohn’s Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    • Crohn’s disease
    Investigated Drugs:
    • Guselkumab
    France

  • Study of Ziftomenib with drug combinations for adults with newly diagnosed acute myeloid leukemia with NPM1 or KMT2A genetic changes

    Recruiting

    3 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Daunorubicin Hydrochloride
    • Ziftomenib
    • Azacitidine
    Belgium Czechia France Germany Greece Hungary +4

  • Study on Apixaban, Rivaroxaban, and Aspirin for Preventing Blood Clots in Patients with JAK2V617F-Positive Myeloproliferative Neoplasms

    Recruiting

    4 1 1 1
    Investigated Diseases:
    • Essential thrombocythaemia
    • Myeloproliferative neoplasm
    • Polycythaemia vera
    Investigated Drugs:
    • Acetylsalicylic Acid
    • Apixaban
    • Rivaroxaban
    France

  • Study Comparing Azathioprine and Methotrexate with Adalimumab for Patients with Crohn’s Disease

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Adalimumab
    • Azathioprine
    • Methotrexate
    France

  • Study on Stopping Omalizumab in Patients with Well-Controlled Severe Allergic Asthma After 3 Years of Treatment

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Omalizumab
    France

  • Study Comparing Clarithromycin and Azithromycin for Treating Mycobacterium Avium Complex Lung Infections in Adults

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Mycobacterium avium complex infection
    Investigated Drugs:
    • Azithromycin
    • Clarithromycin
    • Ethambutol Hydrochloride
    France

  • Study on the Effects of Caffeine on Cognitive Function in Patients with Early to Moderate Alzheimer’s Disease

    Recruiting

    3 1
    Investigated Drugs:
    • Caffeine
    France

  • Study Comparing CPX-351 and Chemotherapy for Patients with New Intermediate or High-Risk Acute Myeloid Leukemia

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Acute myeloid leukaemia
    Investigated Drugs:
    • Daunorubicin
    • Cytarabine
    • Idarubicin
    France

  • Study on Blood Pressure Management with Amiloride Hydrochloride, Indapamide, and Furosemide for Patients with Uncontrolled Hypertension and Chronic Kidney Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic kidney disease
    • Hypertension
    Investigated Drugs:
    • Amiloride Hydrochloride
    • Furosemide
    • Hydrochlorothiazide
    France

  • Study on the Benefits of Autologous Stem Cell Transplantation for Patients with Peripheral T-cell Lymphoma Using Etoposide and Drug Combination

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Peripheral T-cell lymphoma unspecified
    Investigated Drugs:
    • Brentuximab Vedotin
    • Methylprednisolone Hemisuccinate
    • Cyclophosphamide Monohydrate
    Belgium France
1 2
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!